全文获取类型
收费全文 | 3380篇 |
免费 | 185篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 80篇 |
妇产科学 | 28篇 |
基础医学 | 412篇 |
口腔科学 | 49篇 |
临床医学 | 216篇 |
内科学 | 925篇 |
皮肤病学 | 75篇 |
神经病学 | 186篇 |
特种医学 | 153篇 |
外科学 | 663篇 |
综合类 | 12篇 |
预防医学 | 71篇 |
眼科学 | 32篇 |
药学 | 130篇 |
中国医学 | 6篇 |
肿瘤学 | 521篇 |
出版年
2024年 | 7篇 |
2023年 | 47篇 |
2022年 | 89篇 |
2021年 | 136篇 |
2020年 | 92篇 |
2019年 | 106篇 |
2018年 | 117篇 |
2017年 | 88篇 |
2016年 | 123篇 |
2015年 | 109篇 |
2014年 | 157篇 |
2013年 | 138篇 |
2012年 | 250篇 |
2011年 | 236篇 |
2010年 | 136篇 |
2009年 | 102篇 |
2008年 | 208篇 |
2007年 | 212篇 |
2006年 | 169篇 |
2005年 | 200篇 |
2004年 | 191篇 |
2003年 | 170篇 |
2002年 | 140篇 |
2001年 | 31篇 |
2000年 | 29篇 |
1999年 | 35篇 |
1998年 | 24篇 |
1997年 | 23篇 |
1996年 | 20篇 |
1995年 | 13篇 |
1994年 | 12篇 |
1993年 | 23篇 |
1992年 | 18篇 |
1991年 | 11篇 |
1990年 | 12篇 |
1989年 | 13篇 |
1988年 | 3篇 |
1987年 | 12篇 |
1986年 | 12篇 |
1985年 | 9篇 |
1983年 | 7篇 |
1981年 | 6篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1976年 | 4篇 |
1974年 | 4篇 |
1973年 | 4篇 |
1970年 | 3篇 |
1969年 | 8篇 |
1968年 | 3篇 |
排序方式: 共有3587条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
Asahina Y Tsuchiya K Muraoka M Tanaka K Suzuki Y Tamaki N Hoshioka Y Yasui Y Katoh T Hosokawa T Ueda K Nakanishi H Itakura J Takahashi Y Kurosaki M Enomoto N Nitta S Sakamoto N Izumi N 《Hepatology (Baltimore, Md.)》2012,55(1):20-29
Innate immunity plays an important role in host antiviral response to hepatitis C viral (HCV) infection. Recently, single nucleotide polymorphisms (SNPs) of IL28B and host response to peginterferon α (PEG-IFNα) and ribavirin (RBV) were shown to be strongly associated. We aimed to determine the gene expression involving innate immunity in IL28B genotypes and elucidate its relation to response to antiviral treatment. We genotyped IL28B SNPs (rs8099917 and rs12979860) in 88 chronic hepatitis C patients treated with PEG-IFNα-2b/RBV and quantified expressions of viral sensors (RIG-I, MDA5, and LGP2), adaptor molecule (IPS-1), related ubiquitin E3-ligase (RNF125), modulators (ISG15 and USP18), and IL28 (IFNλ). Both IL28B SNPs were 100% identical; 54 patients possessed rs8099917 TT/rs12979860 CC (IL28B major patients) and 34 possessed rs8099917 TG/rs12979860 CT (IL28B minor patients). Hepatic expressions of viral sensors and modulators in IL28B minor patients were significantly up-regulated compared with that in IL28B major patients (≈ 3.3-fold, P < 0.001). However, expression of IPS-1 was significantly lower in IL28B minor patients (1.2-fold, P = 0.028). Expressions of viral sensors and modulators were significantly higher in nonvirological responders (NVR) than that in others despite stratification by IL28B genotype (≈ 2.6-fold, P < 0.001). Multivariate and ROC analyses indicated that higher RIG-I and ISG15 expressions and RIG-I/IPS-1 expression ratio were independent factors for NVR. IPS-1 down-regulation in IL28B minor patients was confirmed by western blotting, and the extent of IPS-1 protein cleavage was associated with the variable treatment response. CONCLUSION: Gene expression involving innate immunity is strongly associated with IL28B genotype and response to PEG-IFNα/RBV. Both IL28B minor allele and higher RIG-I and ISG15 expressions and RIG-I/IPS-1 ratio are independent factors for NVR. 相似文献
95.
We report a patient with ventral simultanagnosia, prosopagnosia for “unfamiliar faces” (dorsal prosopagnosia), spatial agraphia, and constructional disorder, particularly on the left spatial side, due to a lesion in the right posterior superior and middle temporal gyri and angular gyrus. The patient showed impairment of fundamental visual and visuospatial recognition, such as in object size, configuration, and horizontal point location, which probably underlay the mechanism of simultanagnosia and prosopagnosia. This case also suggests that the coexistence of simultanagnosia and prosopagnosia results from a right hemispheric insult, and damage to the temporoparietal area interrupts the incorporation of spatial information into object recognition. This disconnection of information flow, together with impaired object recognition per se, may impair the parallel processing of multiple objects, leading to object-by-object or part-by-part recognition. 相似文献
96.
97.
Hironobu Shigaki Yoshifumi Baba Masayuki Watanabe Keisuke Miyake Asuka Murata Shiro Iwagami Takatsugu Ishimoto Masaaki Iwatsuki Naoya Yoshida Hideo Baba 《Annals of surgical oncology》2013,20(3):485-491
Background
Epidermal growth factor receptor (EGFR) signaling is one of the most promising targets for molecular-targeted therapies in esophageal squamous cell carcinoma (ESCC). Thus, the molecular diagnosis of KRAS and BRAF mutations is clinically important in therapeutic decision making. However, the frequency of KRAS and BRAF mutations in ESCCs remains inconclusive because of the limited sample sizes of previous studies (all N ≤ 80). Pyrosequencing is a nonelectrophoretic nucleotide extension sequencing technology that can be used for mutation testing.Methods
The frequency of KRAS and BRAF mutations was examined using a nonbiased database of 203 resected ESCCs and a high-throughput pyrosequencing assay.Results
The validity of the KRAS pyrosequencing method was initially demonstrated by detection of all 4 types of KRAS mutations [c.35G>T (codon 12 GGT>GTT), c.35G>A (codon 12 GGT>GAT), c.34G>T (codon 12 GGT>TGT), c.38G>A mutation (codon 13 GGC>GAC)], which had been previously diagnosed using Scorpion-ARMS technology, in 9 colon cancer tissues (9 of 9; 100 %). Similar results were demonstrated for BRAF mutational status in 3 colon cancer cell lines (HCT116, Colo201, and HT29), which were validated by Sanger dideoxy sequencing. Subsequently, the KRAS mutation was found to be extremely rare (1 of 203; 0.5 %), and the BRAF mutation was absent (0 of 203; 0 %), in the dataset of 203 ESCCs.Conclusions
These results suggest that KRAS and BRAF mutations play a limited role in the development of ESCC and that mutation analysis is not useful as a screening test for sensitivity to anti-EGFR therapy in ESCC.98.
Yoshiaki Murakami Kenichiro Uemura Takeshi Sudo Yasushi Hashimoto Naru Kondo Naoya Nakagawa Takeshi Muto Hayato Sasaki Kazuhide Urabe Taijiro Sueda 《Journal of gastrointestinal surgery》2013,17(8):1429-1439
Background
The significance of perineural invasion in extrahepatic cholangiocarcinoma has not been fully elucidated. This study aims to determine the prognostic impact of and optimal treatment strategy for perineural invasion in patients with extrahepatic cholangiocarcinoma.Methods
Medical records of 133 patients with extrahepatic cholangiocarcinoma who underwent curative resection were reviewed retrospectively. Ninety-eight patients had perineural invasion and 35 patients did not. Univariate and multivariate survival analyses were performed to clarify the prognostic impact of and optimal treatment strategy for perineural invasion.Results
Only tumor differentiation (P?=?0.024) was independently associated with perineural invasion in the multivariate logistic regression model. Multivariate survival analysis revealed that perineural invasion (P?=?0.002), resection margin status (P?=?0.016), and International Union Against Cancer (UICC) pT factor (P?=?0.015) were independent prognostic factors of overall survival. Overall 5-year survival rates for patients with and without perineural invasion were 28 and 74 %, respectively. Among 98 patients with perineural invasion, the use of adjuvant chemotherapy (P?=?0.003), lymph node status (P?=?0.015), resection margin status (P?=?0.008), and UICC pT factor (P?=?0.016) were independently associated with overall survival by multivariate analysis. Overall 5-year survival rates for patients with perineural invasion who did and did not receive adjuvant chemotherapy were 33 and 21 %, respectively (P?=?0.023).Conclusions
Perineural invasion is a potent prognostic factor in extrahepatic cholangiocarcinoma. Adjuvant chemotherapy may improve the overall survival of patients with perineural invasion. 相似文献99.